.png){kind=icon}
返回
Type 2 diabetes
.png){kind=icon}
PRE
AI
DOI：10.1016/S0140-6736(22)01655-5.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Type 2 diabetes accounts for nearly 90% of the approximately 537 million cases of diabetes worldwide. The number affected is increasing rapidly with alarming trends in children and young adults (up to age 40 years). Early detection and proactive management are crucial for prevention and mitigation of microvascular and macrovascular complications and mortality burden. Access to novel therapies improves person-centred outcomes beyond glycaemic control. Precision medicine, including multiomics and pharmacogenomics, hold promise to enhance understanding of disease heterogeneity, leading to targeted therapies. Technology might improve outcomes, but its potential is yet to be realised. Despite advances, substantial barriers to changing the course of the epidemic remain. This Seminar offers a clinically focused review of the recent developments in type 2 diabetes care including controversies and future directions.
Keyword:
LIFE-STYLE INTERVENTION
OBSTRUCTIVE SLEEP-APNEA
INSULIN PUMP THERAPY
GLYCEMIC CONTROL
DOUBLE-BLIND
CARDIOVASCULAR-DISEASE
PHYSICAL-ACTIVITY
WEIGHT-LOSS
TREATMENT SATISFACTION
CARDIOMETABOLIC RISK
期刊
IF:
88.5
论文数:
5.4W
被引数:
34.8W
机构
引用论文
Preparation and characteristics of cellulose nanowhisker reinforced acrylic foams synthesized by freeze-casting冷冻浇铸法合成纤维素纳米晶须增强丙烯酸泡沫的制备及性能.png)
RSC Advances
RSC AdvancesIF0
PREAI
分享收藏Collateral Damage of the COVID-19 Pandemic on Nutritional Quality and Physical Activity: Perspective from South KoreaOBESITY
OAAI
OBESITYIF4.7
OAAI分享收藏Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trialLANCETOAAI
LANCETIF88.5
OAAI分享收藏Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonistCELL METABOLISM
OAAI
CELL METABOLISMIF30.9
OAAI分享收藏The Lancet Commission on diabetes: using data to transform diabetes care and patient lives柳叶刀糖尿病委员会: 利用数据改变糖尿病护理和患者生活LANCET
LANCETIF88.5
PREAI
分享收藏Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study2型糖尿病的长期血糖变异性和血管并发症: 现场研究的事后分析OAAI
OAAI分享收藏
查看更多内容